Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH)

Clinical trial NCT04032067 · COMPLETED

Trial details

NCT number: NCT04032067
Sponsor: GemVax & Kael
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia (BPH)

Start date: 2019-10-30
Primary completion: 2022-03-17
Enrollment: 423

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.